Rx（處方）醫療食品市場：按產品類型、治療用途、分銷渠道、地區 - 規模、份額、展望、機會分析，2022-2030 年

醫療食品是一類食品，用於控制特定疾病和醫療狀況（例如肺部疾病、胃腸道疾病和代謝紊亂）的飲食控制和預防性治療。 醫療食品中使用的原材料必須是“公認安全的”(GRAS)。 醫療食品不同於營養食品、膳食補充劑和處方藥。 醫療食品以蛋白質、營養成分（omega-3 脂肪酸、螯合鋅、異黃酮）為基礎，可能含有礦物質和維生素，如葉酸和硫胺素。 這些產品由醫生開處方或在醫生的監督下服用。 美國食品和藥物管理局 (FDA) 將醫療食品分為四大類：營養完全產品、營養不完全產品、代謝紊亂製劑和口服補液溶液。 美國食品和藥物管理局 (FDA) 根據孤兒藥法案 (1988) 單獨監管醫療食品，以確保公共安全並遏制聲稱可以治癒疾病的產品的存在。我來了。 醫用食品不需要上市前批准、研究性新藥 (IND) 指定或在 FDA 單獨註冊。 然而，醫療食品需要通過適當的實驗室和臨床研究來支持□□所有健康聲明。

市場動態

在預測期內，各種監管機構合作等有機戰略的興起預計將推動全球 Rx（處方）醫療食品市場。 例如，2021 年 10 月，印度食品安全與標準局 (FSSAI) 宣布食品加工業部 (MoFPI)、農民生產者組織 (FPO)、微觀食品企業家、自助團體 (SHG)和生產者合作社簽訂了一項協議，以幫助提高其食品業務的標準。 該協議包括食品安全培訓和微型企業註冊和許可。 FSSAI 和 MoFPI 協助微型企業獲得和註冊 FSSAI 許可證。

這項研究的主要特點

• 本報告對全球 Rx（處方）醫療食品市場進行了深入分析，顯示了以 2021 年為基準年的預測期（2022-2030 年）的市場規模和復合年增長率 (CAGR%) . 提供。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供有關市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭策略的重要見解。
• 根據公司亮點、產品組合、關鍵亮點、績效和戰略等參數介紹全球 Rx 醫療食品市場主要參與者的概況。
• 本研究涵蓋的主要公司包括雅培實驗室、達能公司、美贊臣公司、費森尤斯卡比公司、雀巢公司、Primus Pharmaceuticals, Inc.、Targeted Medical Pharma Inc.、Pivo□□tal Therapeutics Inc.、VAYA Pharma, Inc.、Lanfam 和 AlfaSigma S.P.A.
• 這份報告中的見解將使營銷人員和企業高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。我猜。
• 《全球 Rx 醫療食品市場報告》針對該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球 Rx（處方）醫療食品市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第2章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 按產品類型劃分的市場概況
  • 市場概況：按治療應用分類
  • 市場概況：按分銷渠道
  • 市場概況：按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 技術概覽
• 監管情景
• 價格分析
• 害蟲分析

第 4 章 Rx（處方）醫療食品的全球市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 政府舉措
• COVID-19 對市場的影響

第 5 章全球 Rx（處方）醫療食品市場：按產品類型，2017-2030

• 藥丸
• 粉末
• 液體
• 其他（威化餅、咀嚼片、棒狀食品）

第 6 章按治療用途劃分的 Rx（處方）醫療食品全球市場：2017-2030

• 疼痛管理
• 神經系統疾病
• 消化系統疾病
• 呼吸系統疾病
• 代謝性疾病
• 其他（纖維化、透析、艾滋病等）

第 7 章全球 Rx（處方）醫療食品市場：按分銷渠道，2017-2030

• 零售藥房
• 在線藥店

第 8 章全球 Rx 醫療食品市場：按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Abbott Laboratories
• Danone S.A.
• Mead Johnson & Company, LLC.
• Fresenius Kabi AG
• Nestle S.A.
• Primus Pharmaceuticals, Inc.
• Targeted Medical Pharma Inc.
• Pivotal Therapeutics Inc.
• VAYA Pharma, Inc.
• Lanfam
• AlfaSigma S.P.A.

第 10 章

• 調查方法
• 關於出版商

Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have 'generally recognized as safe' (GRAS) status. Medical food is different from nutritional food, dietary supplements, and prescription drugs. Medical food is protein-based, nutrient-based (Omega 3 fatty acids, chelated zinc, and isoflavones), and may contain minerals and vitamins such as folic acid and thiamine. These products are prescribed by physicians or taken under their supervision. The U.S. Food & Drug Administration (FDA) has classified medical foods into four major categories; nutritionally complete products, nutritionally incomplete products, formulas for metabolic disorders, and oral rehydration solutions. The U.S. Food and Drug Administration separately regulates medical food under Orphan Drug Act (1988) to ensure safety of populace and curb presence of products falsely claiming to cure medical conditions. Medical food does not require premarket approval, specification as an investigational new drug (IND), and individual registration with the FDA. However, they are required to support all their health claims with proper laboratory and clinical studies.

Market Dynamics

Increasing number of organic strategies such as collaboration by the various regulatory authorities is expected to drive the global Rx medical food market over the forecast period. For instance, in October 2021, Food Safety and Standards Authority of India (FSSAI) had signed an agreement with Ministry of Food Processing Industries (MoFPI) to support Farmer Producer Organizations (FPOs), Micro Level Food Entrepreneurs, Self Help Groups (SHGs) and Producers Cooperatives to improve the standards of their food business. This agreement will include food safety training and Registration & License of the Micro Enterprises. FSSAI and MoFPI support micro enterprises for obtaining FSSAI license and registration.

Key features of the study:

• This report provides an in-depth analysis of the global Rx medical food market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global Rx medical food market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Abbott Laboratories, Danone S.A., Mead Johnson & Company, LLC, Fresenius Kabi AG, Nestle S.A., Primus Pharmaceuticals, Inc., Targeted Medical Pharma Inc., Pivotal Therapeutics Inc., VAYA Pharma, Inc., Lanfam and AlfaSigma S.P.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global Rx medical food market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Rx medical food market

Detailed Segmentation:

• Global Rx Medical Food Market, By Product Type:
  • Pills
  • Powder
  • Liquid
  • Others (Wafers, Chewable and Bars)
• Global Rx Medical Food Market, By Therapeutic Application:
  • Pain Management
  • Neurological Disorders
  • Gastrointestinal Disorders
  • Pulmonary Disorders
  • Metabolic Disorders
  • Others (Fibrosis, Dialysis, AIDS, etc.)
• Global Rx Medical Food Market, By Distribution Channel:
  • Retail Pharmacies
  • Online Pharmacies
• Global Rx Medical Food Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Abbott Laboratories*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Danone S.A.
  • Mead Johnson & Company, LLC.
  • Fresenius Kabi AG
  • Nestle S.A.
  • Primus Pharmaceuticals, Inc.
  • Targeted Medical Pharma Inc.
  • Pivotal Therapeutics Inc.
  • VAYA Pharma, Inc.
  • Lanfam
  • AlfaSigma S.P.A.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Product Type
  • Market Snapshot, By Therapeutic Application
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis

4. Global Rx Medical Food Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Rx Medical Food Market, By Product Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pills
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Powder
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Liquid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others (Wafers, Chewable, and Bars)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Rx Medical Food Market, By Therapeutic Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Pain Management
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Neurological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Gastrointestinal Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Pulmonary Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Metabolic Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others (Fibrosis, Dialysis, AIDS, etc.)
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Rx Medical Food Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Rx Medical Food Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Danone S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mead Johnson & Company, LLC.
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Fresenius Kabi AG
  • Company Highlight
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Nestle S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Primus Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Targeted Medical Pharma Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Pivotal Therapeutics Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• VAYA Pharma, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Lanfam
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• AlfaSigma S.P.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us